Standard Operating Procedure for In-house Preparation of (131)I-rituximab for Radioimmunotherapy of Non-Hodgkin's Lymphoma

A Standard Operating Procedure (SOP) has been formulated for in-house preparation, quality control, dispensing and administration of (131)I-rituximab appropriate for the safe, effective, radioimmunotherapy of non-Hodgkin lymphoma. A decade of experience of semi-automated radioiodination of rituximab...

Descripción completa

Detalles Bibliográficos
Autores principales: Pickford, Matthew D., Turner, J. Harvey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555353/
https://www.ncbi.nlm.nih.gov/pubmed/23372447
http://dx.doi.org/10.4103/1450-1147.103408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555353/
https://www.ncbi.nlm.nih.gov/pubmed/23372447
http://dx.doi.org/10.4103/1450-1147.103408

Ejemplares similares